Related Experiment Videos
[Bendotiamine efficacy in alcoholic polyneuropathy therapy]
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|January 29, 2002
Summary
Benfogamma effectively treats alcoholic polyneuropathy, reducing pain and sensory issues. Neurophysiological tests confirm improvements in nerve function after a six-week treatment course.
Area of Science:
- Neurology
- Pharmacology
Background:
- Alcoholic polyneuropathy is a common complication of chronic alcoholism.
- Pain and sensory disturbances significantly impact patient quality of life.
Purpose of the Study:
- To evaluate the efficacy of Benfogamma in treating alcoholic polyneuropathy with pain syndrome.
- To assess the impact of Benfogamma on sensorimotor and neurological functions.
Main Methods:
- A 6-week therapeutic regimen using Benfogamma (450 mg/day for 2 weeks, then 300 mg/day for 4 weeks).
- Clinical neurophysiological examinations were performed before and after treatment.
- Study included 14 males with stage II-III chronic alcoholism.
Main Results:
- Observed regression of pain, sensory, and movement disorders.
- Reported improvement in neuropathy symptoms.
- Neurophysiological data supported positive changes at peripheral and segmental nerve system levels.
Conclusions:
- Benfogamma demonstrates efficacy in managing alcoholic polyneuropathy symptoms.
- Treatment with Benfogamma leads to measurable improvements in nerve function.